Wilson W M, Walsh S J, Bagnall A, Yan A T, Hanratty C G, Egred M, Smith E, Oldroyd K G, McEntegart M, Irving J, Douglas H, Strange J, Spratt J C
Royal Melbourne Hospital, Department of Cardiology, Parkville VIC 3050, Melbourne, Australia.
Department of Cardiology, Belfast Health and Social Care Trust, Belfast, Ireland.
Catheter Cardiovasc Interv. 2017 Nov 1;90(5):703-712. doi: 10.1002/ccd.26980. Epub 2017 Mar 15.
We aimed to determine clinical outcomes 1 year after successful chronic total occlusion (CTO) PCI and, in particular, whether use of dissection and re-entry strategies affects clinical outcomes. Hybrid approaches have increased the procedural success of CTO percutaneous coronary intervention (PCI) but longer-term outcomes are unknown, particularly in relation to dissection and re-entry techniques. Data were collected for consecutive CTO PCIs performed by hybrid-trained operators from 7 United Kingdom (UK) centres between 2012 and 2014. The primary endpoint (death, myocardial infarction, unplanned target vessel revascularization) was measured at 12 months along with angina status. One-year follow up data were available for 96% of successful cases (n = 805). In total, 85% of patients had a CCS angina class of 2-4 prior to CTO PCI. Final successful procedural strategy was antegrade wire escalation 48%; antegrade dissection and re-entry (ADR) 21%; retrograde wire escalation 5%; retrograde dissection and re-entry (RDR) 26%. Overall, 47% of CTOs were recanalized using dissection and re-entry strategies. During a mean follow up of 11.5 ± 3.8 months, the primary endpoint occurred in 8.6% (n = 69) of patients (10.3% (n = 39/375) in DART group and 7.0% (n = 30/430) in wire-based cases). The majority of patients (88%) had no or minimal angina (CCS class 0 or 1). ADR and RDR were used more frequently in more complex cases with greater disease burden, however, the only independent predictor of the primary endpoint was lesion length. CTO PCI in complex lesions using the hybrid approach is safe, effective and has a low one-year adverse event rate. The method used to recanalize arteries was not associated with adverse outcomes. © 2017 Wiley Periodicals, Inc.
我们旨在确定成功实施慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)1年后的临床结局,尤其是采用夹层分离和重回真腔策略是否会影响临床结局。混合手术方法提高了CTO经皮冠状动脉介入治疗(PCI)的手术成功率,但长期结局尚不清楚,特别是与夹层分离和重回真腔技术相关的结局。收集了2012年至2014年间英国7个中心接受混合培训的术者连续进行CTO PCI的数据。在12个月时测量主要终点(死亡、心肌梗死、非计划靶血管血运重建)以及心绞痛状态。96%的成功病例(n = 805)有1年的随访数据。总体而言,85%的患者在CTO PCI前加拿大心血管学会(CCS)心绞痛分级为2 - 4级。最终成功的手术策略为正向导丝升级48%;正向夹层分离和重回真腔(ADR)21%;逆向导丝升级5%;逆向夹层分离和重回真腔(RDR)26%。总体而言,47%的CTO采用夹层分离和重回真腔策略实现再通。在平均11.5±3.8个月的随访期间,主要终点发生在8.6%(n = 69)的患者中(DART组为10.3%(n = 39/375),基于导丝的病例组为7.0%(n = 30/430))。大多数患者(88%)无心绞痛或心绞痛轻微(CCS分级为0或1级)。ADR和RDR在疾病负担更重的更复杂病例中使用更频繁,然而,主要终点的唯一独立预测因素是病变长度。采用混合手术方法对复杂病变进行CTO PCI是安全、有效的,且1年不良事件发生率低。动脉再通所采用的方法与不良结局无关。© 2017威利期刊公司